10x Genomics Blog ١ يونيو ٢٠٢٦ 10x Genomics CEO Sells Nearly 30,000 Shares. Here's What That Means for Investors. - The Motley Fool
WuXi Biologics ١ يونيو ٢٠٢٦ BRIEF: WuXi Biologics maintains full-year revenue guidance for up to 17% growth - thebambooworks.com
Revvity ١ يونيو ٢٠٢٦ Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - TradingView
Agilent ١ يونيو ٢٠٢٦ StockWatch: Agilent Shares Jump on Better than Expected Quarterly Results - Genetic Engineering and Biotechnology News
eLife ١ يونيو ٢٠٢٦ Mural cells protect the adult brain from hemorrhage but do not control the blood–brain barrier in developing zebrafish
eLife ١ يونيو ٢٠٢٦ Interplay between cohesin and TORC1 links chromosome segregation and gene expression to environmental changes
eLife ١ يونيو ٢٠٢٦ Distinct evolutionary trajectories of two integration centres, the central complex and mushroom bodies, across Heliconiini butterflies
eLife ١ يونيو ٢٠٢٦ Beta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis
FierceBiotech ٣١ مايو ٢٠٢٦ ASCO: Lilly exec points to ‘nutty’ 100% response rate for in vivo CAR-T as justifying Kelonia buyout
FierceBiotech ٣١ مايو ٢٠٢٦ ASCO: Revolution Medicines confident in RAS leadership as rivals square up
FierceBiotech ٣١ مايو ٢٠٢٦ ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
Endpoints News ٣١ مايو ٢٠٢٦ #ASCO26: Summit, Akeso drug reduces death by 34% in China lung cancer study